This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
What the researchers found
Omiganan liposomal gel reduced pro-inflammatory cytokines and improved skin lesions significantly compared to conventional formulations.
Why it matters
This research highlights a potential new treatment for chronic skin conditions, which can significantly impact patients' quality of life. The findings could lead to better therapeutic options in dermatology.
How the study worked
The study involved creating liposomes encapsulating Omiganan and evaluating their efficacy in mice models of atopic dermatitis and psoriasis.
What this study cannot tell us
The study was conducted in mice, and results may not directly translate to humans. Further clinical trials are needed.
Read the original research
Liposomes encapsulating novel antimicrobial peptide Omiganan: Characterization and its pharmacodynamic evaluation in atopic dermatitis and psoriasis mice model.
International journal of pharmaceutics, 624, 122045
Citation
Javia, Ankit; Misra, Ambikanandan; Thakkar, Hetal. (2022). Liposomes encapsulating novel antimicrobial peptide Omiganan: Characterization and its pharmacodynamic evaluation in atopic dermatitis and psoriasis mice model.. International journal of pharmaceutics, 624, 122045. https://doi.org/10.1016/j.ijpharm.2022.122045